Roberto Contieri
Overview
Explore the profile of Roberto Contieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, et al.
BJU Int
. 2025 Feb;
PMID: 39967051
Objective: To assess the oncological outcomes of patients with high-risk (HR) and very high-risk (VHR) non-muscle-invasive bladder cancer (NMIBC) treated with upfront radical cystectomy (RC) vs Bacillus Calmette-Guérin (BCG) instillations...
2.
Contieri R, Guigui A, Gondran-Tellier B, Basile G, Zattoni F, Gallioli A, et al.
Int Urol Nephrol
. 2025 Feb;
PMID: 39934553
Introduction: To evaluate whether adherence to specific quality criteria in the management of T1 non-muscle-invasive bladder cancer (NMIBC) undergoing second-look transurethral resection of bladder tumor (TURBT) leads to improved oncological...
3.
Hurle R, Contieri R, Lazzeri M
World J Urol
. 2025 Feb;
43(1):113.
PMID: 39928159
No abstract available.
4.
Advancing Surgical Management of Penile Cancer: Single Port Bilateral Inguinal Lymph Node Dissection
Perdona S, Izzo A, Tufano A, Passaro F, Quarto G, Aveta A, et al.
Int Braz J Urol
. 2025 Feb;
51(3).
PMID: 39908203
Introduction: Penile cancer is a rare but aggressive malignancy, with inguinal lymph node involvement representing a key prognostic indicator (1, 2). NCCN guidelines recommend prophylactic inguinal lymph node dissection (ILND)...
5.
Hurle R, Bernardini B, Contieri R, Lazzeri M
Eur Urol
. 2025 Feb;
PMID: 39904710
No abstract available.
6.
Saouli A, Zerda I, Elkhader K, Durand X, Ariane M, Quhal F, et al.
World J Urol
. 2025 Jan;
43(1):95.
PMID: 39883196
Objective: This systematic review was conducted to synthesize current research on the role of repeated transurethral resection of the bladder (re-TURB) and the emerging use of magnetic resonance imaging (MRI)...
7.
Bernardini B, Piccioni F, Pastore M, Casale P, Buffi N, Lughezzani G, et al.
BJUI Compass
. 2025 Jan;
6(1):e376.
PMID: 39877577
Background: Despite guideline recommendations, few institutions have implemented clinical pathways that incorporate frailty into routine decision-making for patients undergoing radical cystectomy (RC). This paper presents an integrated clinical pathway designed...
8.
Beatrici E, De Carne F, Frego N, Moretto S, Paciotti M, Fasulo V, et al.
Prostate
. 2025 Jan;
e24862.
PMID: 39876544
Introduction: We aim to critically assess Microultrasound (mUS) clinical performance in an outpatient setting, focusing on its ability to reduce unnecessary diagnostic procedures, potentially reshape prostate cancer (PCa) diagnostic protocols,...
9.
Sordelli F, Desai A, Dagnino F, Contieri R, Giuriolo S, Paciotti M, et al.
Eur Urol Open Sci
. 2025 Jan;
71():172-179.
PMID: 39845740
Background And Objective: Bladder cancer (BC) represents a significant health care challenge and is frequently detected during evaluations for haematuria in emergency departments (EDs). Our aim was to evaluate the...
10.
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Massiet A, Dutto D, et al.
BJU Int
. 2025 Jan;
PMID: 39797535
Objective: To evaluate the oncological efficacy and safety of sequential intravesical gemcitabine/docetaxel (Gem/Doce) therapy in a European cohort of patients with high-risk and very-high-risk non-muscle-invasive bladder cancer (NMIBC) after previous...